Alliance Growers Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Alliance Growers's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals Industry Growth | 6.0% |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Last Earnings Update | 31 May 2019 |
Recent past performance updates
No updates
Recent updates
In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Alliance Growers has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.
Show sectionRevenue & Expenses BreakdownBeta
How Alliance Growers makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 May 19 | 0 | -3 | 1 | 0 |
28 Feb 19 | 0 | -3 | 1 | 0 |
30 Nov 18 | 0 | -6 | 4 | 0 |
31 Aug 18 | 0 | -5 | 4 | 0 |
31 May 18 | 0 | -4 | 4 | 0 |
28 Feb 18 | 0 | -4 | 4 | 0 |
30 Nov 17 | 0 | -2 | 2 | 0 |
31 Aug 17 | 0 | -2 | 2 | 0 |
31 May 17 | 0 | -1 | 1 | 0 |
28 Feb 17 | 0 | -1 | 1 | 0 |
30 Nov 16 | 0 | -1 | 1 | 0 |
31 Aug 16 | 0 | 0 | 0 | 0 |
31 May 16 | 0 | -1 | 0 | 0 |
29 Feb 16 | 0 | -1 | 0 | 0 |
30 Nov 15 | 0 | -1 | 0 | 0 |
31 Aug 15 | 0 | -1 | 0 | 0 |
Quality Earnings: Insufficient data to determine if ALGW.F has high quality earnings.
Growing Profit Margin: Insufficient data to determine if ALGW.F's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if ALGW.F's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare ALGW.F's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if ALGW.F's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: ALGW.F has a negative Return on Equity (0%), as it is currently unprofitable.